STAAR Surgical (NASDAQ:STAA) Major Shareholder Buys $453,986.30 in Stock

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. acquired 21,155 shares of the business’s stock in a transaction that occurred on Tuesday, January 14th. The shares were purchased at an average cost of $21.46 per share, for a total transaction of $453,986.30. Following the completion of the transaction, the insider now directly owns 10,869,786 shares in the company, valued at $233,265,607.56. The trade was a 0.20 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, January 16th, Broadwood Partners, L.P. purchased 8,221 shares of STAAR Surgical stock. The shares were purchased at an average price of $21.50 per share, for a total transaction of $176,751.50.
• On Wednesday, December 18th, Broadwood Partners, L.P. acquired 23,000 shares of STAAR Surgical stock. The stock was purchased at an average price of $24.33 per share, with a total value of $559,590.00.
• On Monday, December 16th, Broadwood Partners, L.P. bought 53,500 shares of STAAR Surgical stock. The stock was acquired at an average cost of $24.24 per share, with a total value of $1,296,840.00.

STAAR Surgical Trading Up 2.0 %

Shares of NASDAQ STAA opened at $22.29 on Friday. STAAR Surgical has a 12-month low of $21.13 and a 12-month high of $52.68. The firm has a market capitalization of $1.10 billion, a price-to-earnings ratio of 50.66 and a beta of 0.63. The firm has a 50 day moving average of $25.38 and a 200 day moving average of $31.83.

Institutional Investors Weigh In On STAAR Surgical

A number of hedge funds have recently modified their holdings of STAA. Dimensional Fund Advisors LP lifted its position in STAAR Surgical by 25.9% during the second quarter. Dimensional Fund Advisors LP now owns 459,655 shares of the medical instruments supplier’s stock valued at $21,884,000 after purchasing an additional 94,422 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of STAAR Surgical by 137.5% during the 2nd quarter. Renaissance Technologies LLC now owns 68,400 shares of the medical instruments supplier’s stock valued at $3,257,000 after buying an additional 39,600 shares in the last quarter. Edgestream Partners L.P. purchased a new position in shares of STAAR Surgical during the 2nd quarter valued at about $390,000. Mutual of America Capital Management LLC grew its stake in shares of STAAR Surgical by 214.7% during the 2nd quarter. Mutual of America Capital Management LLC now owns 26,459 shares of the medical instruments supplier’s stock valued at $1,260,000 after acquiring an additional 18,051 shares during the period. Finally, Hsbc Holdings PLC increased its holdings in STAAR Surgical by 12.4% in the 2nd quarter. Hsbc Holdings PLC now owns 10,290 shares of the medical instruments supplier’s stock worth $492,000 after acquiring an additional 1,137 shares in the last quarter. Institutional investors own 96.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Stephens raised STAAR Surgical to a “hold” rating in a research report on Monday, December 2nd. Needham & Company LLC reaffirmed a “hold” rating on shares of STAAR Surgical in a report on Tuesday, January 7th. Finally, Canaccord Genuity Group decreased their price objective on shares of STAAR Surgical from $31.00 to $28.00 and set a “hold” rating for the company in a report on Monday, December 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $42.83.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.